NMPA Approval

Recombinant Human Interferon α2a for Injection

Approval Number

国药准字S10980104

Company辽宁卫星生物制品研究所（有限公司）

Registration Date

June 24, 2020

Drug Information

Generic Name

注射用重组人干扰素α2a

Trade Name

迪恩安

Brand Name

迪恩安

Dosage Form

注射剂

Strength

600万IU

Drug Type

生物制品

Registration Date

June 24, 2020

Company Information

Applicant Company

Company Name辽宁卫星生物制品研究所（有限公司）

Manufacturing Company

Company Name辽宁卫星生物制品研究所（有限公司）

Company Address

沈阳市大东区东站街51甲-3号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用重组人干扰素α2a - NMPA 批准文号 | MedPath